130 related articles for article (PubMed ID: 4773075)
21. [Determination of acetylator phenotype of isoniazid by superimposed sinusodial tension polarography].
Vallon JJ; Badinand A; Bichon C
Eur J Toxicol Environ Hyg; 1976; 9(3):155-64. PubMed ID: 954852
[TBL] [Abstract][Full Text] [Related]
22. Classification of subjects as slow or rapid inactivators of isoniazid, based on the ratio of the urinary excretion of acetylisoniazid to isoniazid.
Venkataraman P; Menon NK; Nair NG; Radhakrishna S; Ross C; Tripathy SP
Tubercle; 1972 Jun; 53(2):84-91. PubMed ID: 5040582
[No Abstract] [Full Text] [Related]
23. The rate of isoniazid inactivation in Finnish diabetic and non-diabetic patients.
Mattila MJ; Tiitinen H
Ann Med Exp Biol Fenn; 1967; 45(4):423-7. PubMed ID: 5599058
[No Abstract] [Full Text] [Related]
24. Clinical pharmacokinetics of isoniazid.
Weber WW; Hein DW
Clin Pharmacokinet; 1979; 4(6):401-22. PubMed ID: 391461
[TBL] [Abstract][Full Text] [Related]
25. Determination of isonicotinic acid in the presence of isoniazid and acetylisoniazid. Studies on isonicotinic acid formation from isoniazid in isolated rat hepatocytes.
Ono Y; Noda A; Zaima Y; Jitsufuchi N; Eto S; Noda H
J Chromatogr B Biomed Appl; 1996 Mar; 677(2):339-43. PubMed ID: 8704939
[TBL] [Abstract][Full Text] [Related]
26. A sensitive urine-test method for monitoring the ingestion of isoniazid.
Ellard GA; Greenfield
J Clin Pathol; 1977 Jan; 30(1):84-7. PubMed ID: 838875
[TBL] [Abstract][Full Text] [Related]
27. [Evaluation of the isoniazid dosimetry which uses a rapid and simple technic for the determination of the acetylator phenotype].
Kergueris MF; Le Normand Y; Veyrac MJ; Ortega A; Larousse C
Therapie; 1978; 33(6):735-42. PubMed ID: 746520
[No Abstract] [Full Text] [Related]
28. Ion-pair high-performance liquid chromatographic determination of isoniazid and acetylisoniazid in plasma and urine. Application for acetylator phenotyping.
Svensson JO; Muchtar A; Ericsson O
J Chromatogr; 1985 May; 341(1):193-7. PubMed ID: 4019685
[No Abstract] [Full Text] [Related]
29. Acetylator phenotyping with sulphadimidine in patients receiving isoniazid.
Ylitalo P; Auterinen L; Marttinen A; Koivula T
Int J Clin Pharmacol Res; 1984; 4(2):141-4. PubMed ID: 6469440
[TBL] [Abstract][Full Text] [Related]
30. Acetylator phenotyping: a comparison of the isoniazid and dapsone tests.
Hanson A; Melander A; Wåhlin-Boll E
Eur J Clin Pharmacol; 1981; 20(3):233-4. PubMed ID: 7286042
[TBL] [Abstract][Full Text] [Related]
31. Acetylation phenotype in rheumatoid arthritis.
Oka M; Seppälä O
Scand J Rheumatol; 1978; 7(1):29-30. PubMed ID: 675172
[TBL] [Abstract][Full Text] [Related]
32. The determination of the acetylator phenotype of tuberculosis patients in Czechoslovakia using sulphadimidine.
Víznerová A; Slavíková Z; Ellard GA
Tubercle; 1973 Mar; 54(1):67-71. PubMed ID: 4774936
[No Abstract] [Full Text] [Related]
33. A more simple, rapid and sensitive fluorimetric method for the determination of isoniazid and acetylisoniazid in serum. Application for acetylator phenotyping.
Ioannou PC
Clin Chim Acta; 1988 Jul; 175(2):175-81. PubMed ID: 3409532
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of isoniazid: influence of age.
Kergueris MF; Bourin M; Larousse C
Eur J Clin Pharmacol; 1986; 30(3):335-40. PubMed ID: 3732371
[TBL] [Abstract][Full Text] [Related]
35. Increased urinary excretion of toxic hydrazino metabolites of isoniazid by slow acetylators. Effect of a slow-release preparation of isoniazid.
Peretti E; Karlaganis G; Lauterburg BH
Eur J Clin Pharmacol; 1987; 33(3):283-6. PubMed ID: 3691615
[TBL] [Abstract][Full Text] [Related]
36. Effect of coadministration of procainamide and isoniazid on each other's acetylation pathway.
Schneck DW; Sprouse JS; Shiroff RA; Vary JE; DeWitt FO; Hayes AH
Pharmacology; 1979; 18(1):34-41. PubMed ID: 419159
[TBL] [Abstract][Full Text] [Related]
37. Simplified screening test for phenotyping of isoniazid inactivators.
Eidus L; Hodgkin MM
Int J Clin Pharmacol; 1973 Feb; 7(1):82-6. PubMed ID: 4699389
[No Abstract] [Full Text] [Related]
38. Genetically determined variability in acetylation and oxidation. Therapeutic implications.
Clark DW
Drugs; 1985 Apr; 29(4):342-75. PubMed ID: 2859977
[TBL] [Abstract][Full Text] [Related]
39. Isoniazid acetylation rates (phenotypes) of patients being treated for tuberculosis.
Mason E; Russell DW
Bull World Health Organ; 1971; 45(5):617-24. PubMed ID: 5316954
[TBL] [Abstract][Full Text] [Related]
40. [Acetylation phenotype of isoniazid in Morocco. Preliminary study of 100 cases].
Bouayad Z; Chevalier B; Maurin R; Bartal M
Rev Fr Mal Respir; 1982; 10(6):401-7. PubMed ID: 7163595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
